Article
Surgical management of hemorrhagic strokes caused by coumadin-related coagulopathy
Search Medline for
Authors
Published: | June 8, 2016 |
---|
Outline
Text
Objective: Chronic warfarin anticoagulation is the most effective therapy for attenuating the risk of stroke associated with atrial fibrilliation. Intracranial hemorrhage is the most feared and lethal complication of coumadin. We review the surgical results of intracranial hemorrhages caused by coumadin-related hemorrhagic strokes in one cardiovascular center.
Method: We reviewed retrospectively 74 consecutive patients admitted with hemorrhagic stroke (spontaneous ICH or subdural hematoma) who is taking coumadin for the anticoagulation for the past ten years in our cardiovascular center.? Demographics: Age 61 (40-77). 59 % were females.
Results: The mean coumadin dose was 3.94 mg and their mean initial PT INR was 3.09 (ranging 1.17 to 7.32). The spontaneous subdural hematoma was more common than the lobar ICH (43 to 31 = 1.38 : 1). The reoperation rate was higher with 10 % (7/74 cases). The overall mortality was 39.1 % (29/74) much higher than the 10 % mortality rate of usual hypertensive ICH, but lower than the usual 65 % fatality of coumadin-related ICH.
Conclusions: Subdural hematoma was more common than the intracerebral hematoma. Surgical evacuation was helpful to improve the outcome of the patient who had the considerable amount of hematoma caused by coumadin.